November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Identification of Resistance Biomarkers to HER2 Inhibitors
Jul 27, 2024, 14:49

Identification of Resistance Biomarkers to HER2 Inhibitors

Iván González, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post on X about a paper titled “Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer” published in MDPI.

Authors: Alvan Cai, Yuan Chen, Lily S. Wang, John K. Cusick and Yihui Shi.

Identification of Resistance Biomarkers to HER2 Inhibitors

Identification of Resistance Biomarkers to HER2 Inhibitors: Advances and Challenges in HER2+ Breast Cancer.

  • Therapeutic advances: HER2 inhibitors have significantly improved the treatment of HER2+ breast cancer.
  • Persistent challenge: Resistance to these drugs remains a critical issue.
  • Key biomarkers identified: Mutations in the ERBB2 gene, activation of alternative signaling pathways, expression of estrogen receptors, and alterations in regulatory protein levels have been found.
  • New explorations: More effective regimens and promising combination therapies are being investigated.

This review highlights current HER2-targeted therapies, analyzes predictive biomarkers of drug resistance, and presents emerging therapies, especially combination treatments, aimed at overcoming resistance in the context of HER2+ breast cancer.”

Identification of Resistance Biomarkers to HER2 Inhibitors

Source: Iván González/X